Viking Therapeutics announced its oral formulation of VK2735 has scored in a Phase I trial at ObesityWeek 2024.

Travel Expert Kathy Kennedy and Inspire Wine Bar owner Talina Zsido, get us ready for the “Holiday Spirits Event” taking place November 19th at Inspire Wine Bar. Please watch the video ...

Nov 3, 2024; Minneapolis, Minnesota, USA; Minnesota Vikings tight end Josh Oliver (84) catches a pass for a touchdown against the Indianapolis Colts in the fourth quarter at U.S. Bank Stadium. / Brad ...

Novo Nordisk reports earnings Wednesday morning, with sales of blockbuster weight-loss drugs Ozempic and Wegovy expected to continue driving the Danish drugmaker's results higher.

Truist Financial analyst Joon Lee assigned a Buy rating to the stock today. The company’s shares closed last Friday at $72.88. Lee covers ...

Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on Viking Therapeutics (VKTX – Research Report) today and set a price ...

Pills are displayed with open pill bottles on top of a white counter top in the kitchen.Viking Therapeutics (VKTX) released ...

Viking Therapeutics reported an 8.2% weight loss with VK2735, but a sell-off followed. Read why VKTX stock's long-term ...

The biotech had tested the oral asset, dubbed VK2735, at doses ranging from 2.5 mg up to 100 mg. Viking already revealed back in March that 25% of the eight patients who received 20-mg doses saw their ...

Shares of Viking Therapeutics (NASDAQ:VKTX) jumped 22% Monday morning after the biotech firm reported promising results for ...

Rare first-quarter pick: Both the Colts and Vikings exchanged turnovers to start Sunday's game, the latter coming after ...

The best of Australia’s travel industry has been named in the National Travel Industry Awards. The banquet hall at the ...